Letrazolo (Femara) CAS 112809-51-5

Prodcut name: Letrazolo
Altro nome: Femara
CAS: 12809-51-5
Aspetto: polvere bianca
Grado: Pharmaceutical grade
Pacchetto: Disguised package ; Foil bag
Delivery date: 3-5 work days
Purezza: >99%
MF: 306.44
MW: 285.30274

Product application

Letrazole Is a type II (nonsteroidal) third generation aromatase inhibitor. Clinically used for the treatment of estrogen receptor-positive or estrogen receptor unknown breast cancer in postmenopausal women.
In women with breast cancer, estrogen levels have been reduced by more than 98%.

Tuttavia, its use is not limited to the elimination of estrogen in women.
For the bodybuilder before the game, Femara is almost necessary to eliminate water retention conditions, and to achieve in today’s fitness world in the necessary torn appearance of competition. Tuttavia, according to my experience, only need to use in the past 4-6 weeks to eliminate excessive estrogen and water retention. After using Femara, I recommend not to suppress any estrogen for at least a month in an attempt to normalize the body.